… with cisplatin/paclitaxel appeared to improve survival over chemotherapy alone … due to the incident cancer, 3.2% due to … primary [head and neck cancer], in the absence of … locally recurrent head and neck cancer. ClinicalTrials.gov. Updated November …

… cancer involves a combination of chemotherapy and immunotherapy. Standard Combination: Gemcitabine and cisplatin (chemotherapy … genetic mutations, doctors may use drugs like Pemazyre (pemigatinib) ( … a substitute for professional medical advice, as your own …

… cautioned that several commonly prescribed medicines can have 'quietly devastating … exposure.” Certain chemotherapy drugs (Methotrexate, Cisplatin) “While life-saving, some cancer treatments can affect …

… ) for patients with cisplatin-ineligible muscle-invasive bladder cancer (MIBC). In this … with prior experience in bladder cancer. He also contextualized the significance … a longstanding unmet need for cisplatin-ineligible patients and highlighted remaining …

… rather than cisplatin-based doublet) chemotherapy with pembrolizumab … al. Safety, pharmacokinetics (PK), pharmacodynamics (PD) and … precision medicine strategy to combat cancer. Mol Cancer Ther … antibody-drug conjugates in breast cancer. Cancer Drug Resist. …

… ICG and the chemotherapeutic drug DOX, into biocompatible … related to personalized medicine. Manufacturing and scale … Hyaluronic acid-modified cisplatin-encapsulated poly(lactic- … NIR-responsive chemo-photothermal combination cancer therapy. Pharmaceutics. 2023 …

… resistance to chemotherapeutic agents like cisplatin, paclitaxel … and overcomes drug resistance, unmasking … Traditional Chinese Medicine (NO. 2021SK4023 … Pharmacological inhibition of noncanonical EED-EZH2 signaling overcomes chemoresistance in prostate cancer …

… aware. Three medical professionals failed to see the cancer that a nurse … gone. Reading this study while cisplatin was pumped through my veins … radiation burns and weeks of chemo-induced vomiting and hospitalizations will …

… silencing the upstream regulator chemokine CXCL5—attenuate cuproptosis, … cisplatin-induced and septic AKI.5,23 Pharmacologically … Project for Regional Medical Center Construction under … target for overcoming cancer drug resistance. Drug Resist Updates. 2024 …

… in Physiology and Medicine was awarded to … -2055 alongside 5-FU, cisplatin, and cetuximab (NCT01360827) … , Datar Cancer Genetics, EISAI, EMD Serono, EOM Pharmaceuticals, Iylon, … lung cancer patients who have progressed following chemotherapy. Cancer Immunol …